Fundraising Fox

Menten AI

YC W20

San Francisco, US Β· 2 employees Β· 3 known investors

menten.ai β†—

Menten AI develops generative AI software to design cyclic peptide therapeutics for drug targets beyond the reach of conventional small molecules and biologics. The company partners with major pharmaceutical firms to accelerate preclinical drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryQuantum Computingin /menten-ai@menten_ai

Founders & leadershipΒ· Y Combinator alumni (W20)

Tamas Gorbe
Tamas Gorbein𝕏Founder
Hans Melo
Hans MeloinFounder

Investors Β· 3

Y Combinatorβœ“ verifiedMountain View Β· $500K – $500K
Khosla Venturesβœ“ verifiedMenlo Park
Uncork Capitalβœ“ verifiedSan Francisco Β· $3M – $5M

In the news